000 | 01398 a2200421 4500 | ||
---|---|---|---|
005 | 20250515031633.0 | ||
264 | 0 | _c20061024 | |
008 | 200610s 0 0 eng d | ||
022 | _a0024-7758 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElliott, Kevin S | |
245 | 0 | 0 |
_aLong-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients. _h[electronic resource] |
260 |
_bThe Journal of reproductive medicine _cMay 2006 |
||
300 |
_a383-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHysterectomy |
650 | 0 | 4 | _aLymph Node Excision |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xmortality |
700 | 1 | _aBorowsky, Mark E | |
700 | 1 | _aMalka, Edmond S | |
700 | 1 | _aScudder, Sidney A | |
700 | 1 | _aLeiserowitz, Gary S | |
700 | 1 | _aRussell, Anthony H | |
773 | 0 |
_tThe Journal of reproductive medicine _gvol. 51 _gno. 5 _gp. 383-8 |
|
999 |
_c16374591 _d16374591 |